In short. Most lumps and spots are harmless, but the decision to biopsy is deliberate. How dermoscopy, sampling technique, and pathology reporting work together.
Key points
- Removing a lesion and only then sending it for examination is reasonable for clearly benign growths, but it is poor practice when cancer is suspected, because an incompletely removed tumour distorts the site and complicates the definitive operation.
- When there is genuine doubt, the sequence should be examination, dermoscopy, and then a biopsy taken with the diagnosis in mind.
Most lumps, bumps, and spots on the skin are benign. Seborrheic keratoses look as though they have been stuck onto the skin, dermatofibromas are firm dimpled nodules on the limbs, lipomas are soft movable lumps beneath the skin, and epidermoid cysts are round swellings with a central punctum. The clinical problem is not identifying these; it is reliably distinguishing them from the minority of lesions that are not benign.
How the decision is made
Dermoscopy — examination with a magnifier and polarised light — has changed this process substantially, allowing a trained eye to see structural features invisible to the naked eye. The features that raise concern are consistent: a lesion changing in size, shape, or colour; one that itches, bleeds, crusts, or fails to heal; and any new lesion in older skin or in someone immunosuppressed. Previous skin cancer raises suspicion further.
The biopsy: technique follows the question
A biopsy is not one procedure. A punch biopsy takes a small cylindrical core and suits inflammatory rashes and many lumps. A shave removes a superficial lesion flush with the skin. An excision removes the whole lesion, and when skin cancer is suspected it is performed with a narrow margin and the specimen oriented so pathology can report on the edges. The full lesion should be sent rather than partially sampled whenever cancer is possible, because partial sampling can miss the diagnosis. The report that returns — diagnosis, depth, and whether margins are clear — determines everything that follows.
A biopsy is a diagnostic test, not a shortcut
Removing a lesion and only then sending it for examination is reasonable for clearly benign growths, but it is poor practice when cancer is suspected, because an incompletely removed tumour distorts the site and complicates the definitive operation. When there is genuine doubt, the sequence should be examination, dermoscopy, and then a biopsy taken with the diagnosis in mind.
Treatment classes and follow-up
Treatment ranges from observation, through removal by shave, curettage, or excision, to surgical excision with margin control when a malignant lesion is confirmed. Premalignant lesions such as actinic keratoses may be treated with field-directed topical therapy or destructive techniques, because the surrounding skin is usually affected too. Follow-up intervals are set by the diagnosis and the person’s risk profile, and skin self-examination is taught rather than recommended.
Honest limits
Dermoscopy is not histology, and even experienced examiners occasionally revise an impression after the pathologist reports. Sampling error is real: a biopsy takes a small piece of a lesion that may be varied throughout. Benign lesions are sometimes removed because they catch on clothing or worry the person, and that is a legitimate reason. What should never happen is a lesion being watched indefinitely when no one can say with confidence what it is.
Arrange assessment promptly if
- A mole or spot is changing in size, shape, or colour, or looks different from your other moles — change is the most important warning sign.
- A lesion bleeds, crusts, itches, or fails to heal over several weeks, or a sore recurs in the same place — non-healing lesions need examination.
- You have had a skin cancer before, are immunosuppressed, or have extensive sun damage — regular specialist skin checks are part of your care.
Frequently asked questions
How does a dermatologist decide whether a lesion needs biopsy?
By examination with a magnifier and polarised light, which reveals structural features invisible to the naked eye. Concern is raised by a lesion changing in size, shape, or colour, one that itches, bleeds, crusts, or fails to heal, or any new lesion in older or immunosuppressed skin.
Does the type of biopsy matter?
It does. A punch biopsy takes a small cylindrical core for inflammatory rashes and many lumps, a shave removes a superficial lesion flush with the skin, and an excision removes the whole lesion with a narrow margin when skin cancer is suspected.
Why should a suspected cancer not simply be removed first?
Because an incompletely removed tumour distorts the site and complicates the definitive operation, and partial sampling can miss the diagnosis. When there is genuine doubt, the sequence is examination, dermoscopy, then a biopsy taken with the diagnosis in mind.
Risks & Limitations
- Most chronic skin disease is managed rather than cured, and relapse is expected.
- Treatments typically need 8–12 weeks before response can be judged fairly.
- Topical treatment can cause irritation, dryness, peeling and photosensitivity.
- Systemic therapy may require blood monitoring and carries organ, metabolic and pregnancy risks.
- Isotretinoin in particular requires strict monitoring and pregnancy prevention.
- Pigment change is often slow and may be incomplete.
- No treatment works for everyone, and response cannot be predicted with certainty.
When to Seek Care
- A mole or lesion that changes in size, shape or colour, or starts to bleed, itch or crust.
- Fever with a widespread rash, blistering, or rash involving the eyes, mouth or genitals — seek emergency care.
- Rapidly spreading redness, swelling or pain in the skin.
- Facial swelling or difficulty breathing — possible severe reaction; seek emergency care immediately.
- New or worsening symptoms while taking a monitored medication.
References & Further Reading
- American Academy of Dermatology (AAD) — public and clinical guidance
- World Health Organization (WHO) — skin and infectious disease resources
- Chinese Medical Association, Dermatology Branch — clinical guidance
- Cochrane Library — systematic reviews in dermatology
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.